共 65 条
[1]
Richardson S(2020)Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized With COVID-19 in the New York city area JAMA 323 2052-2059
[2]
Hirsch JS(1963)The cellular nature of genetic susceptibility to a virus J Exp Med 117 781-798
[3]
Narasimhan M(1970)In vitro interaction of mouse hepatitis virus and macrophages from genetically resistant mice. I. Adsorption of virus and growth curves J Exp Med 131 843-50
[4]
Kantoch M(1977)Blocking of in vitro and in vivo susceptibility to mouse hepatitis virus J Exp Med 146 1467-1472
[5]
Warwick A(2020)Targets of T Cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals Cell 181 1489-1501.e15
[6]
Bang FB(2020)Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial JAMA 324 460-470
[7]
Shif I(2020)Remdesivir for the treatment of Covid-19—preliminary report N Engl J Med 3 CD013881-400
[8]
Bang FB(2021)Interleukin-6 blocking agents for treating COVID-19: a living systematic review Cochrane Database Syst Rev 50 397-undefined
[9]
Weiser WY(2020)Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients Med Mal Infect undefined undefined-undefined
[10]
Bang FB(2020)Dexamethasone in hospitalized patients with Covid-19—preliminary report N Engl J Med undefined undefined-undefined